Cargando…

Patient harm from cardiovascular medications

BACKGROUND: Medication harm can lead to hospital admission, prolonged hospital stay and poor patient outcomes. Reducing medication harm is a priority for healthcare organisations worldwide. Recent Australian studies demonstrate cardiovascular (CV) medications are a leading cause of harm. However, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paradissis, Chariclia, Cottrell, Neil, Coombes, Ian, Scott, Ian, Wang, William, Barras, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317255/ https://www.ncbi.nlm.nih.gov/pubmed/34367546 http://dx.doi.org/10.1177/20420986211027451

Ejemplares similares

Scoping Review of Studies Evaluating Frailty and Its Association with Medication Harm
por: Lam, Jonathan Yong Jie, et al.
Publicado: (2022)

Correction to: Scoping Review of Studies Evaluating Frailty and Its Association with Medication Harm
por: Lam, Jonathan Yong Jie, et al.
Publicado: (2022)

Experiences and learnings of pharmacists, students, and clinical assistants working collaboratively in a COVID-19 vaccination clinic: a qualitative study
por: Paradissis, Chariclia, et al.
Publicado: (2023)

The impact of hospital-based post-discharge pharmacist medication review on patient clinical outcomes: A systematic review
por: Costello, Jaclyn, et al.
Publicado: (2023)

Identifying medication harm in hospitalised patients: a bimodal, targeted approach
por: Falconer, Nazanin, et al.
Publicado: (2020)

Investigating strategies used by hospital pharmacists to effectively communicate with patients during medication counselling
por: Chevalier, Bernadette A. M., et al.
Publicado: (2017)

Reducing Medical Admissions into Hospital through Optimising Medicines (REMAIN HOME) Study: protocol for a stepped-wedge, cluster-randomised trial
por: Foot, Holly, et al.
Publicado: (2017)

Reducing the Risk of Harm From Medication Errors in Children
por: Neuspiel, Daniel R., et al.
Publicado: (2013)

Medication‐Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention
por: Hayward, Kelly L., et al.
Publicado: (2019)

Using Discursis to enhance the qualitative analysis of hospital pharmacist-patient interactions
por: Chevalier, Bernadette A. M., et al.
Publicado: (2018)

Psychological Treatment of Medical Patients Struggling with Harmful Substance Use
por: Belcinski, Donna
Publicado: (2020)

Benefits and Harms of COVID-19 Vaccines in Cardiovascular Disease: A Comprehensive Review
por: Chen, Chung-Yen, et al.
Publicado: (2023)

Use of a patient-centred educational exchange (PCEE) to improve patient’s self-management of medicines after a stroke: a randomised controlled trial study protocol
por: Coombes, Judith Ann, et al.
Publicado: (2018)

Astaxanthin in Cardiovascular Health and Disease
por: Fassett, Robert G., et al.
Publicado: (2012)

Islamic Jurisprudence on Harm Versus Harm Scenarios in Medical Confidentiality
por: Muhsin, Sayyed Mohamed
Publicado: (2023)

To Do No Harm: A Journey Through Medical School
por: Chen, Fabian
Publicado: (1987)

Standardising the Classification of Harm Associated with Medication Errors: The Harm Associated with Medication Error Classification (HAMEC)
por: Gates, Peter J., et al.
Publicado: (2019)

Rethinking Medical Aid in Dying: What Does It Mean to ‘Do No Harm?’
por: Lawry, Dallas R.
Publicado: (2023)

Astaxanthin: A Potential Therapeutic Agent in Cardiovascular Disease
por: Fassett, Robert G., et al.
Publicado: (2011)

Physical Activity in Polluted Air—Net Benefit or Harm to Cardiovascular Health? A Comprehensive Review
por: Hahad, Omar, et al.
Publicado: (2021)

Medical Machiavellianism: the tradeoff between benefit and harm with targeted chemotherapy
por: Oronsky, Bryan, et al.
Publicado: (2016)

Book Review: Lesser harms: the morality of risk in medical research
por: Löwy, Ilana
Publicado: (2006)

Benefits and harms of mammography screening
por: Løberg, Magnus, et al.
Publicado: (2015)

First Do No Harm: Medication‐Related Problems Among Patients With Cirrhosis
por: Aye, Lydia, et al.
Publicado: (2019)

Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review
por: Lo, Lindsay A., et al.
Publicado: (2023)

E-Cigarettes—a review of the evidence—harm versus harm reduction
por: Feeney, Susan, et al.
Publicado: (2022)

Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms
por: Roberts, Ian, et al.
Publicado: (2017)

Cardiovascular Effects of Calcium Supplements
por: Reid, Ian R.
Publicado: (2013)

Medical Records: Law, Paternalism and Harm
por: Feenan, Dermot
Publicado: (1995)

Substance use and self-harm: a cross-sectional study of the prevalence, correlates and patterns of medical service utilisation among patients admitted to a South African hospital
por: Breet, Elsie, et al.
Publicado: (2018)

Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review
por: Alqenae, Fatema A., et al.
Publicado: (2020)

Medication Utilisation Program, Quality Improvement and Research Pharmacist—Implementation Strategies and Preliminary Findings
por: Whitfield, Karen, et al.
Publicado: (2021)

Alcohol and the Cardiovascular System: Molecular Mechanisms for Beneficial and Harmful Action
por: Zakhari, Sam
Publicado: (1997)

What happened to “Patient first” and “Do no harm” medical principles?
por: Ghaly, Ramsis F., et al.
Publicado: (2018)

Implementation of Bar-Code Medication Administration to Reduce Patient Harm
por: Thompson, Kristine M., et al.
Publicado: (2018)

Tobacco harm reduction: an alternative cessation strategy for inveterate smokers
por: Rodu, Brad, et al.
Publicado: (2006)

Computational identification of harmful mutation regions to the activity of transposable elements
por: Jin, Lingling, et al.
Publicado: (2017)

BRAF Mutation in Colorectal Cancer: An Update
por: Barras, David
Publicado: (2015)

Effectiveness, acceptability and potential harms of peer support for self-harm in non-clinical settings: systematic review
por: Abou Seif, Nada, et al.
Publicado: (2022)

Schistosome: Its Benefit and Harm in Patients Suffering from Concomitant Diseases
por: Osada, Yoshio, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4kq517msvc3ut5g4v3vij1mvv4